{
  "id": 462,
  "text": "# 9.1.5 Recurrence Despite of significantly more IA2 patients having positive regional LNs ( $1 .2 \\%$ (IA1) versus LoE 1- $3 .7 \\%$ (IA2), $\\mathrm { ~ p ~ } = \\ 0 .0 0 2 \\$ , the recurrence rates between IA1 and IA2 patients were not significantly different in the pooled analysis published by Hou et al.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: # 9.1.5 Recurrence Despite of significantly more IA2 patients having positive regional LNs ( $1 .2 \\%$ (IA1) versus LoE 1- $3 .7 \\%$ (IA2), $\\mathrm { ~ p ~ } = \\ 0 .0 0 2 \\$ , the recurrence rates between IA1 and IA2 patients were not significantly different in the pooled analysis published by Hou et al.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "根据研究结果，在IA1和IA2分期的患者中，尽管IA2阶段的患者区域淋巴结阳性概率显著高于IA1阶段（1.2% 对比 3.7%，p = 0.002），但综合分析显示两者的复发率并无显著性差异。",
  "query": "在IA1和IA2分期的患者中，尽管IA2阶段有更多患者出现区域淋巴结阳性，是否两者的复发率存在显著性差异？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在IA1和IA2分期的患者中，尽管IA2阶段有更多患者出现区域淋巴结阳性，是否两者的复发率存在显著性差异？\n\n<reference text>: # 9.1.5 Recurrence Despite of significantly more IA2 patients having positive regional LNs ( $1 .2 \\%$ (IA1) versus LoE 1- $3 .7 \\%$ (IA2), $\\mathrm { ~ p ~ } = \\ 0 .0 0 2 \\$ , the recurrence rates between IA1 and IA2 patients were not significantly different in the pooled analysis published by Hou et al.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "根据研究结果，在IA1和IA2分期的患者中，尽管IA2阶段的患者区域淋巴结阳性概率显著高于IA1阶段（1.2% 对比 3.7%，p = 0.002），但综合分析显示两者的复发率并无显著性差异。"
}